Skip to content
by Legal Desire
4 October 2023

Latham & Watkins Advises on the Transfer of LimaCorporate From EQT to Enovis

M&A Healthcare & Life Sciences Expected to close

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Cataldo Piccarreta Lead Latham & Watkins LLP Partner corporate Not stated
Maria Giulia De Cesari Latham & Watkins LLP Associate corporate Not stated
Federica Di Terlizzi Latham & Watkins LLP Associate corporate Not stated
Sebastian Max Hauser Latham & Watkins LLP Partner antitrust Not stated
Giuseppe Liotine Latham & Watkins LLP Associate antitrust Not stated
Joseph Kimberling Latham & Watkins LLP Partner finance Not stated
Patrick Kwak Latham & Watkins LLP Partner finance Not stated
Jason Morelli Latham & Watkins LLP Partner finance Not stated
Yoseph Choi Latham & Watkins LLP Counsel finance Not stated
Taniel Akay Latham & Watkins LLP Associate finance Not stated
Medha Vikram Latham & Watkins LLP Associate finance Not stated
Cesare Milani Latham & Watkins LLP Partner regulatory Not stated
Edoardo Cassinelli Latham & Watkins LLP Associate regulatory Not stated

10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Not stated
Counterparties
EQT Private Equity (Sell-side)
Enovis™ Corporation (Buy-side)
LimaCorporate S.p.A. (Target)